Language
Select Language
Main Number: 571.350.8400
Clinical Trials: 703.636.1473
New Patient
Refer a Patient
Virginia Cancer Specialists logo

Dr. Mitul Gandhi, Medical Oncologist at Virginia Cancer Specialists, Co-Authors Real-World Study Assessing Efficacy of Azacitidine in Treatment-Naive Patients with Higher-Risk Myelodysplastic Syndromes

Cancer in the blood outbreak and treatment for malignant cells in a human body caused by carcinogens and genetics with a cancerous cell as an immun...

Dr. Mitul Gandhi, Medical Oncologist at Virginia Cancer Specialists, Co-Authors Real-World Study Assessing Efficacy of Azacitidine in Treatment-Naive Patients with Higher-Risk Myelodysplastic Syndromes This study highlights the need for new therapies that improve complete remission and survival rates in patients with HR-MDS. Fairfax, Virginia, February 9, 2024 – Virginia Cancer Specialists, a premier provider of […]

Brentuximab Vedotin: A Promising Frontline Therapy for Older Hodgkin Lymphoma Patients

Destruction of leukaemia cell, conceptual image. 3D illustration which can be used to illustrate blood cancer treatment

A recent study published by Dr. Dipti Patel-Donnelly, of Virginia Cancer Specialists and colleagues has shed light on a groundbreaking approach in the treatment of advanced-stage classical Hodgkin lymphoma (cHL) in older patients. This noncomparative phase 2 study, detailed in the research article here, explores the efficacy of brentuximab vedotin (BV) in combination with dacarbazine […]